These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21083020)

  • 1. Prognostic tools in follicular lymphomas.
    Luminari S; Cox MC; Montanini A; Federico M
    Expert Rev Hematol; 2009 Oct; 2(5):549-62. PubMed ID: 21083020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of follicular lymphomas.
    Luminari S; Federico M
    Hematol Oncol; 2006 Jun; 24(2):64-72. PubMed ID: 16514592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.
    Federico M; Bellei M; Marcheselli L; Luminari S; Lopez-Guillermo A; Vitolo U; Pro B; Pileri S; Pulsoni A; Soubeyran P; Cortelazzo S; Martinelli G; Martelli M; Rigacci L; Arcaini L; Di Raimondo F; Merli F; Sabattini E; McLaughlin P; Solal-Céligny P
    J Clin Oncol; 2009 Sep; 27(27):4555-62. PubMed ID: 19652063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment.
    Arcaini L; Colombo N; Passamonti F; Burcheri S; Orlandi E; Brusamolino E; Della Porta M; Rumi E; Montanari F; Pascutto C; Paulli M; Lazzarino M
    Leuk Res; 2006 Mar; 30(3):277-82. PubMed ID: 16112730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
    Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
    Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
    Klapper W; Hoster E; Rölver L; Schrader C; Janssen D; Tiemann M; Bernd HW; Determann O; Hansmann ML; Möller P; Feller A; Stein H; Wacker HH; Dreyling M; Unterhalt M; Hiddemann W; Ott G;
    J Clin Oncol; 2007 Aug; 25(22):3330-6. PubMed ID: 17664481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in follicular lymphoma.
    Relander T; Johnson NA; Farinha P; Connors JM; Sehn LH; Gascoyne RD
    J Clin Oncol; 2010 Jun; 28(17):2902-13. PubMed ID: 20385990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic significance of gene expression profiling in lymphomas.
    Leich E; Hartmann EM; Burek C; Ott G; Rosenwald A
    APMIS; 2007 Oct; 115(10):1135-46. PubMed ID: 18042147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes and clinical relevance of the Follicular Lymphoma International Prognostic Index in Korean follicular lymphoma patients treated with chemotherapy.
    Maeng CH; Ahn SW; Ryu SY; Han S; Ko YH; Ji JH; Kim WS; Kim SJ
    Korean J Intern Med; 2016 May; 31(3):560-9. PubMed ID: 26898595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of PU.1 in follicular lymphoma.
    Torlakovic EE; Bilalovic N; Golouh R; Zidar A; Angel S
    J Pathol; 2006 Jul; 209(3):352-9. PubMed ID: 16639693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of a workshop on malignant lymphoma: a review of molecular and clinical risk profiling.
    Gleissner B; Küppers R; Siebert R; Glass B; Trümper L; Hiddemann W; Dreyling M
    Br J Haematol; 2008 Jun; 142(2):166-78. PubMed ID: 18492111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of autologous stem cell transplantation for follicular non-Hodgkin lymphoma: effect of histological grade and Follicular International Prognostic Index.
    Vose JM; Bierman PJ; Loberiza FR; Lynch JC; Bociek GR; Weisenburger DD; Armitage JO
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):36-42. PubMed ID: 18158959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantle cell lymphoma: prognostic capacity of the Follicular Lymphoma International Prognostic Index.
    Møller MB; Pedersen NT; Christensen BE
    Br J Haematol; 2006 Apr; 133(1):43-9. PubMed ID: 16512827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting outcome in follicular lymphoma by using interactive gene pairs.
    LeBrun D; Baetz T; Foster C; Farmer P; Sidhu R; Guo H; Harrison K; Somogyi R; Greller LD; Feilotter H
    Clin Cancer Res; 2008 Jan; 14(2):478-87. PubMed ID: 18223222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
    Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
    Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.
    Glas AM; Knoops L; Delahaye L; Kersten MJ; Kibbelaar RE; Wessels LA; van Laar R; van Krieken JH; Baars JW; Raemaekers J; Kluin PM; van't Veer LJ; de Jong D
    J Clin Oncol; 2007 Feb; 25(4):390-8. PubMed ID: 17200149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages.
    Wahlin BE; Aggarwal M; Montes-Moreno S; Gonzalez LF; Roncador G; Sanchez-Verde L; Christensson B; Sander B; Kimby E
    Clin Cancer Res; 2010 Jan; 16(2):637-50. PubMed ID: 20068089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is remission in follicular lymphoma and what is its relevance?
    Buckstein R; Pennell N; Berinstein NL
    Best Pract Res Clin Haematol; 2005 Mar; 18(1):27-56. PubMed ID: 15694183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
    Mandelli F; Petti MC; Lo Coco F
    Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicular lymphomas.
    Vitolo U; Ferreri AJ; Montoto S
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):248-61. PubMed ID: 18359244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.